BWIN:NSD-The Baldwin Insurance Group, Inc. (USD)

COMMON STOCK | Insurance Brokers |

Last Closing

USD 32.68

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.87M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-22 )

Largest Industry Peers for Insurance Brokers

Symbol Name Price(Change) Market Cap
WTW Willis Towers Watson PLC

+0.38 (+0.14%)

USD 26.83B
ERIE Erie Indemnity Company

+3.19 (+0.89%)

USD 18.66B
CRVL CorVel Corp

-0.04 (-0.02%)

USD 4.27B
GOCO GoHealth Inc.

+0.21 (+2.27%)

USD 0.22B
FANH Fanhua Inc

-0.17 (-7.69%)

USD 0.15B
EHTH eHealth Inc

-0.03 (-0.65%)

USD 0.13B
HUIZ Huize Holding Ltd

-0.01 (-0.99%)

USD 0.05B
RELIW Reliance Global Group Inc

-0.02 (-28.95%)

USD 0.04B
TIRX Tian Ruixiang Holdings Ltd

N/A

USD 5.46M
RELI Reliance Global Group Inc

-0.04 (-12.28%)

USD 3.34M

ETFs Containing BWIN

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance Brokers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector